Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.84 USD | +0.56% | +9.68% | -11.59% |
May. 02 | Avanos Medical to Seek M&A Opportunities | CI |
May. 02 | Transcript : Avanos Medical, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Financials (USD)
Sales 2024 * | 694M | Sales 2025 * | 730M | Capitalization | 852M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3,771 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.1% |
Latest transcript on Avanos Medical, Inc.
1 day | +0.25% | ||
1 week | +5.96% | ||
Current month | +9.13% | ||
1 month | +1.18% | ||
3 months | +3.30% | ||
6 months | -9.16% | ||
Current year | -12.04% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Woody
CEO | Chief Executive Officer | 58 | 17-06-25 |
Michael Greiner
DFI | Director of Finance/CFO | 51 | 19-12-31 |
Compliance Officer | - | 20-09-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
CHM | Chairman | 66 | 14-10-30 |
Patrick O'Leary
BRD | Director/Board Member | 66 | 14-10-30 |
Julie Shimer
BRD | Director/Board Member | 71 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 27 M€ | -3.58% | - | |
0.19% | 45 M€ | +2.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 19.83 | +0.51% | 6 824 |
24-05-06 | 19.73 | +0.25% | 208,977 |
24-05-03 | 19.68 | -0.15% | 246,254 |
24-05-02 | 19.71 | +4.90% | 338,205 |
24-05-01 | 18.79 | +3.93% | 360,445 |
Delayed Quote Nyse, May 06, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-12.04% | 852M | |
-4.02% | 184B | |
-0.75% | 109B | |
-2.97% | 68.37B | |
+4.48% | 51.56B | |
+9.09% | 44.69B | |
+4.37% | 41.49B | |
+3.12% | 26.75B | |
+4.10% | 26.7B | |
+15.38% | 25.68B |
- Stock Market
- Equities
- AVNS Stock